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BACKGROUND AND PURPOSE: Stroke is the second commonest cause of death worldwide and a leading cause of severe disability, 
yet there are no published trials of palliative care in stroke. To design and evaluate palliative care interventions for people with 
stroke, researchers need to know what measurable outcomes matter most to patients and families, stroke professionals, and 
other service providers.
METHODS: A multidisciplinary steering group of professionals and laypeople managed the study. We synthesized 
recommendations from respected United Kingdom and international consensus documents to generate a list of outcome 
domains and then performed a rapid scoping literature review to identify potential outcome measures for use in future trials 
of palliative care after stroke. We then completed a 3-round, online Delphi survey of professionals, and service users to build 
consensus about outcome domains and outcome measures. Finally, we held a stakeholder workshop to review and finalize 
this consensus.
RESULTS: We generated a list of 36 different outcome domains from 4 key policy documents. The rapid scoping review 
identified 43 potential outcome measures that were used to create a shortlist of 16 measures. The 36 outcome domains 
and 16 measures were presented to a Delphi panel of diverse healthcare professionals and lay service users. Of 48 
panelists invited to take part, 28 completed all 3 rounds. Shared decision-making and quality of life were selected as 
the most important outcome domains for future trials of palliative care in stroke. Additional comments highlighted the 
need for outcomes to be feasible, measurable, and relevant beyond the initial, acute phase of stroke. The stakeholder 
workshop endorsed these results.
CONCLUSIONS: Future trials of palliative care after stroke should include pragmatic outcome measures, applicable to the 
evolving patient and family experiences after stroke and be inclusive of shared decision-making and quality of life.
GRAPHIC ABSTRACT: An online graphic abstract is available for this article.
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Stroke is a major cause of death and disability, with 5·5 million deaths worldwide attributed to stroke in 2016.1 Case fatality for severe stroke in the 
United Kingdom is about 50% at 6 months, and 90% of 
deaths occur in acute hospitals.2,3 Integrating a palliative 
care approach into management of people with severe 
stroke is appropriate, whether patients die in the acute 
phase or survive with ongoing disabilities and reduced 
life expectancy.4 The 2020 International Association for 
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“Palliative care is the active holistic care of individuals 
across all ages with serious health-related suffering due 
to severe illness, and especially of those near the end 
of life. It aims to improve the quality of life of patients, 
their families and their caregivers.”5 The American Heart 
Association/American Stroke Association 2014 guide-
lines state that “palliative care should be available to all 
patients with serious or life-threatening stroke and their 
families throughout the entire course of the illness.”6 
Potential benefits of a wider palliative care approach 
include improving quality of life as well as care of the 
dying, reducing health-related suffering, and person-cen-
tered care that minimizes use of costly interventions with 
low benefit or potential harms.4,7,8
For 20 years, the World Health Organization has high-
lighted quality of life as a core outcome of palliative care 
achieved by early identification and impeccable assess-
ment and treatment of pain and other problems: physical, 
psychosocial, and spiritual.9 There are no published ran-
domized trials of palliative care in stroke. Given the high 
case fatality in severe stroke, such trials are essential. 
Trials of palliative care for severe stroke require robust 
outcome measures that capture what matters to patients, 
their families, and professionals. However, systematic 
reviews of outcomes in palliative and end-of-life care 
have not included people with stroke who are likely to 
have different needs from those with commonly studied 
conditions such as cancer.10,11 The International Consor-
tium for Health Outcomes Measurement (www.ICHOM.
org) and COMET (Core Outcome Measures in Effective-
ness Trials; www.comet-initiative.org) have no informa-
tion about appropriate outcome measures for palliative 
care in people with stroke. However, qualitative studies 
have shown the need to understand patient and carer 
experiences and address their unmet needs.3,12–15
The aim of this study was to identify a set of outcome 
domains and outcome measures for use in clinical tri-
als of palliative and end-of-life care in stroke. The term 
outcome domain refers to a measurable aspect of a 
condition that matters to patients, family caregivers, and 
clinicians. Outcome measure refers to a specific tool to 
evaluate or assess the effects of an intervention.16
METHODS
The study was managed by a multidisciplinary steering group 
with 15 members, including the project lead (G.E.M.), researcher 
(B.M.), and 2 bereaved carers of people who died after severe 
stroke. These 2 patient-public involvement representatives 
provided important insights throughout the whole study from 
concept to dissemination. The data that support the findings 
of this study are available from the corresponding author upon 
reasonable request. This was a mixed-method, Delphi study 
consisting of 4 stages.
1. Collation and synthesis of potential outcome domains 
from consensus documents and national guidelines in 
palliative care.
2. A rapid scoping literature review of recent trials and inter-
ventions in severe stroke and palliative care to identify 
candidate outcome measures.
3. A Delphi survey with a panel of healthcare profession-
als from stroke services and palliative care along with 
lay members who had personal experiences of stroke to 
generate consensus about the most important outcome 
domains and measures for a future trial.
4. An end-of-study workshop involving the steering group, 
key stakeholders, and Delphi panelists to finalize consen-
sus recommendations.
Outcome Domains
Four expert sources were identified and used for potential 
outcome domains: World Health Organization definition of pal-
liative care, US National Consensus Project Clinical Practice 
Guidelines for Quality Palliative Care Guidelines,17 UK National 
Institute for Clinical Excellence quality statements for palliative 
and end-of-life care,18 and results of a consensus–workshop on 
outcome domains for palliative care from the 2016 European 
Association of Palliative Care meeting.19 Outcome domains 
extracted by the researcher were agreed upon by the project 
lead. A synthesized list for the Delphi survey was agreed upon 
by the project steering group.
Rapid Scoping Literature
We constructed a rapid scoping review by combining the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses–ScR (Scoping Review) protocol20 with the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses protocol for rapid reviews.21 A scoping review 
“identifies knowledge gaps, sets research agendas, and 
identifies implications for decision-making.”22 A rapid review 
streamlines or omits specific methods to produce evidence 
for stakeholders in a resource-efficient manner.21 Our scop-
ing review used rapid methodology and aimed to identify 
diverse study types in a short time frame.22
The steering group advised restricting the search to publica-
tions since January 1, 2015, from one major database for peer-
reviewed evidence (Medline), and one gray literature source, 
Google Scholar. The Cochrane Palliative Care database and 
COMET databases were also searched without date restric-
tions to look for potential outcome measures. We included 
primary research, audits, reviews, and service evaluations that 
reported outcome measures. We excluded studies where the 
abstract or full text was not available and non-English publi-
cations. The short time frame of the project meant that full-
text articles not available from the university library or personal 
subscriptions were excluded (Data I in the Data Supplement; 
search terms and restrictions)
Nonstandard Abbreviations and Acronyms
COMET  Core Outcome Measures in Effective-
ness Trials
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Delphi Survey
A Delphi survey is frequently used for building consensus 
among professionals, service users, and key stakeholders.23–26 
We aimed to complete 3 rounds and recruit at least 23 pan-
elists; this is sufficient to provide stability of results and was 
feasible within available resources.27 We tried to recruit a sub-
stantial number of service users to achieve a broad mix of 
expertise. We used the CREDES (Conducting and Reporting 
Delphi Studies) reporting guidelines for conducting a Delphi 
study in palliative care.28
We conducted the Delphi via Joint Information Systems 
Committee Online Surveys, hosted in the United Kingdom and 
compliant with European Union General Data Protection Rules 
(https://www.onlinesurveys.ac.uk/). Test versions were piloted by 
steering group members and refined to address any accessibility 
or logic issues. Survey data were stored on a secure University 
server. We recruited panelists from professional contacts of the 
steering group, internet searches for experts, our existing links 
with public-patient involvement groups, requests to national pro-
fessional networks, voluntary organizations including stroke chari-
ties, and by posting on the Cochrane Task Exchange (https://
taskexchange.cochrane.org/). Professionals and service users 
identified themselves as experts in palliative care, stroke, or both.
We addressed attrition by sending reminder emails to late 
responders and keeping time between rounds short. The sur-
vey pages had indicators showing progress and an option to 
save and return. Help buttons provided additional information. 
The text density was minimized to improve accessibility and 
readability, with images and formatting used to highlight key 
content. At round 3, panelists were offered a £25 ($US dollar 
35) retail voucher if they completed the survey.
The Delphi utilized an iterative process with the importance 
of outcome domains and the usefulness of outcome measures 
rated on 5-point scales. The consensus level for agreement was 
set at 75% of respondents who completed each rating. If 75% 
of respondents scored an item as 1 to 2 on a 5-point scale, 
consensus for lack of importance or usefulness was reached. 
Conversely, if 75% of respondents scored an item as 4 to 5 
on a 5-point scale that item had consensus for importance or 
usefulness. After each round, any item achieving consensus for 
lack of usefulness or importance was removed. In the second 
and third rounds, and panelists received the scores from previ-
ous rounds. At the end of a round, if 50% of items reached 
the consensus level of 75% for usefulness or importance, the 
rating task for the next round was changed to ranking: rank-
ing required panelists to pick a top 5 ordering them from first 
to fifth. Panelists could add free-text comments during each 
Delphi round which were analyzed thematically.
Stakeholder Meeting
On March 4, 2020, a face-to-face participatory meeting in 
Edinburgh involved the steering group, key stakeholders identi-
fied by the steering group, and available Delphi panelists. Outputs 
from the Delphi were presented for discussion and review to 
reach a final consensus inclusive of multiple perspectives.
Ethical Review
The local National Health Service ethics committee decided 
this project did not require formal ethical review.
RESULTS
Outcome Domains
From the 4 expert consensus sources, 33 individual out-
come domains were extracted and grouped into 9 broad 
domains adapted from the domains listed in the US 
National Consensus Project.
Rapid Scoping Review
The database searches identified 817 titles. After 
duplicates were removed, 720 remained. The project 
researcher conducted initial screening with review by 
the project lead of 100 randomly chosen papers. This 
retrieved 80 full-text articles and 45 of them met the 
inclusion criteria (Figure I and Data II in the Data Sup-
plement). We found no completed clinical trials of pal-
liative care in severe stroke published since 2015 or in 
the 2 databases; COMET and Cochrane Pain, Palliative 
and Supportive Care. One protocol for trial of a person-
centered intervention for informal carers/caregivers of 
stroke survivors (Organising Support for Carers of Stroke 
Survivors [OSCARSS]) has been published since.29 The 
steering group reviewed reports and helped assess inter-
rater reliability. A data extraction table was created, but 
quality assessment using a risk of bias tool was not con-
sidered relevant or appropriate. Of the 45 included stud-
ies, 15 were randomized controlled trials: 13 in stroke 
and 2 in palliative care. In addition, 8 trial protocols were 
included: 7 from stroke and 1 from palliative care. The 
remainder were other quantitative studies, 2 systematic 
reviews, 1 qualitative study, and 1 mixed-method study. 
The studies were predominantly stroke-based: 32 stroke, 
13 palliative care, and 1 combined.
Outcome measures were extracted from the literature 
review data by the researcher with input from the project 
lead. A list of preexisting tools and other outcome mea-
sures was produced. The project steering group reviewed 
the list to generate a consensus set of measures suitable 
to present to a Delphi panel. A total of 43 outcome mea-
sures were extracted including 23 existing tools devel-
oped independently of the study which reported them 
(Data I in the Data Supplement).
The 33 outcome domains and 43 outcome mea-
sures were presented to the steering group on July 
17, 2019. The group retained all 33 domains and 
shortlisted 16 outcome measures. The group added 
3 further outcome domains based on their exper-
tise in stroke or palliative care: “The length of time 
between admission to hospital and discharge to the 
community,” “The length of time between admission 
to hospital and death,” and “Looking back, did you 
achieve the outcome that you hoped to achieve?” 
Outcome domains listed in the same domain group-
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Delphi Results
Recruitment and Retention
Eighty-nine people were invited to participate in the 
Delphi panel; 48 agreed but 1 withdrew before the sur-
vey was circulated. Round 1 was completed by 35 out 
of 47 (75%), round 2 by 30 (64%), and round 3 by 
28 (60%) The overall retention rate was 60%. Table 1 
shows the experience/expertise in stroke or palliative 
care of the panelists. Seven respondents stated that 
they had personal experience of caring for a family 
member with stroke: of these one identified as a stroke 
professional. Of the 6 lay respondents, 5 had experi-
ence of caring for someone who died from a severe 
stroke, and 1 currently cared for a major stroke survi-
vor. Five lay respondents completed all 3 rounds. One 
respondent who identified as a stroke survivor without 
professional experience in stroke or palliative care com-
pleted all 3 rounds. In total, 7 people with personal but 
not professional experience in stroke or palliative care 
(lay respondents) started the Delphi, and 6 completed 
it: a higher retention rate than those who identified their 
expertise as professionals.
Outcome Domains
In the first Delphi round, 31 of the 36 domains were 
rated as “important” to “very important” by at least 75% 
of the panelists (Table I in the Data Supplement). This 
was higher than expected and exceeded the threshold to 
move from rating to ranking. We selected the 12 outcome 
domains that had been rated “important” or “very impor-
tant” by 97% or more of the panelists. In round 2, panel-
ists selected a top 5 from the 12 domains presented. We 
then assigned points: 5 points for first place, down to 1 
point for fifth place. A total score was calculated. This 
approach mirrored the nominal group technique used in 
the European Association of Palliative Care consensus 
workshop.19 For the third round, we removed 5 outcome 
domains scoring under 20, leaving 7 domains to be 
ranked by panelists (Table 2).
The final ranking from round 3 is shown in order of 
priority.
1. Shared decision-making between professionals, 
patients, and family members.
2. Distress around fear of dying or living with severe 
disability the patient is feeling.
3. Whether the patient feels that they are being 
treated and valued as a person.
4. Amount of distress treatment for stroke causes the 
patient.
5. Patient and family perceptions of the quality and 
appropriateness of care.
6. Patient’s ability to understand and respond to com-
munication from others.
7. Amount of pain a patient has.
Outcome Measures
In round 1, none of the 16 outcome measures were rated 
as 4 or 5 (“useful” or “very useful”) by at least 75% of 
panelists so all went through to the next round. In free-
text comments and emails to the project team, some pan-
elists said they did not know the measures well enough 
to make an informed judgment. For round 2, panelists 
were presented with the same outcome measures along 
with the round 1 results for each measure. In this second 
round, 2 of the 16 outcome measures reached consen-
sus level for usefulness: the Distress Thermometer and 
CollaboRATE. Seven outcome measures were not rated 
as “useful” or “very useful” by at least 50% of the panel 
so we removed these for the third round. Nine outcome 
measures were presented to panelists in round 3, again 
with results from previous rounds. In the final round, 4 
outcome measures were rated “useful” or “very useful” 
by 75% of panelists; CollaborRATE (shared decision-
making), then EQ-5D-5L (quality of life), the Integrated 
Palliative Outcome Scale ((https://pos-pal.org/), and the 
Distress Thermometer (Table II in the Data Supplement).
A total of 212 free-text comments from the Delphi 
panelists (123 from professionals and 41 from service 
users) were received and analyzed. Two major themes 
emerged: the need for simple, quick measures and dif-
ficulty finding a tool that is relevant beyond the initial, 
acute phase of stroke.
Stakeholder Meeting
Eight steering group members and 6 Delphi panel-
ists attended. There was agreement about the top 3 
outcome measures. Six outcome domains that did not 
progress from round 1 were considered important to 
patients and families:
• Physical and emotional impact of being an informal 
carer.
• Social isolation of patient and/or family member(s) 
due to the stroke.
• Family perceptions of quality of care for a person in 
their last days of life.
• Whether the patient’s wishes were sought and 
followed.
• Patient’s ability to communicate using language.
• Patient’s own perception of their quality of life.





Round 1 Round 2 Round 3
47 35 30 28
Areas of expertise/experience
 Stroke–professional  25 23 21
 Palliative care–professional  17 15 13
 Stroke–personal experience  7 5 5
  Palliative care–personal 
experience
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Domains relating to patient and family quality of life 
are addressed by the recommended outcome measures 
but other approaches may need to be included.
DISCUSSION
This study aimed to build consensus on important out-
come domains and outcome measures for future trials 
of palliative and end-of-life care in stroke by integrating 
a rapid review of published literature with expert discus-
sion using a Delphi process with professionals and lay 
representatives. The study findings demonstrated the 
importance of measuring shared decision-making and 
quality of life for future trials of palliative care in severe 
stroke. This reflects complex choices about treatment 
and care options in the acute phase of stroke where 
interventions may increase survival but leave people 
with major disability. Shared decision-making is central 
to high-quality healthcare but stroke brings additional 
challenges to patient participation including sudden 
illness, impaired communication, lack of capacity, and 
proxy (substitute) decision-making.13,30 The devastat-
ing impact of severe stroke on the lives of patients and 
families globally is evident.31 Both decision making and 
quality of life evolve over a stroke illness trajectory so 
measures for patients and proxy (substitute) decision-
makers suited to early and later phases were highlighted 
by our panelists and key stakeholders.
There are several strengths to this study. We searched 
both the stroke and the palliative care literature. Two 
bereaved carers of people who died after a stroke were 
involved throughout the project from inception to publi-
cation. Lay people and those with experience of major 
stroke were included in the Delphi study, and all but one 
of them completed the 3 rounds. These lived experiences 
of end-of-life care after stroke improved the validity and 
relevance of our results. The final round of the Delphi still 
had 28 panelists more than the minimum target of 23 
specified in the Delphi methodology.
There are some limitations. Most of the Delphi pan-
elists were United Kingdom based because we want 
to initially develop a palliative care intervention for the 
United Kingdom. However, many aspects of clinical 
decision-making in stroke care are generalizable to other 
countries and health systems, and we reference relevant 
international work. A majority of Delphi panelists were 
professionals, although we tried hard to maximize public-
patient involvement and involved 7 laypeople. Partici-
pants in the Delphi were not asked to disclose protected 
characteristics, such as gender, ethnicity, or race, so this 
study was not able to address cultural context and diver-
sity among professionals, patients, and family caregiv-
ers. This is an important consideration for palliative care 
delivery and future research.32 Some panelists were not 
familiar with all of the outcome measures so it was dif-
ficult to gauge how confident they were in their scoring. 
Conversely, the very high level of agreement over the 
importance of so many of the outcome domains in round 
1 of the Delphi meant that there was no principled way of 
assessing the cutoff point for inclusion in round 2. There-
fore, in our stakeholder workshop, we discussed the out-
comes that had not progressed through the Delphi and 
included those confirmed by laypeople who attended. 
Had the Delphi panel included more laypeople, those 
excluded outcomes might have been rated higher.
The most important domain was shared decision-mak-
ing, and the proposed outcome measure was Collabo-
RATE, a 3-question measure of shared decision-making 
in accessible language that can be completed by patients 
and family members. It has been used mainly in primary 
care and outpatient settings.33 A systematic review of 
instruments to measure the process of shared decision-
making recommended use of measures with good con-
tent validity and inter-rater reliability suited to the aim 
Table 2. Delphi Rounds 2 and 3—Ranking of Outcome Domains by Panelists
Outcome domain Round 2 score* Round 3 score*†
Shared decision-making between professionals, the patient, and family members 86 73
How much distress around fear of dying or living with severe disability the patient is feeling 55 56
Whether the patient feels that they are being treated and valued as a person 53 45
Patient and family perception of the quality and appropriateness of care provided 41 39
Patient’s ability to understand and respond to communication from others 25 12
Amount of distress that treatment for stroke causes the patient 25 39
Amount of pain a patient has 22 12
How anxious or depressed the patient is 18 ...
How well the information needs of the patient and family members are being met 17 ...
Amount of functional ability a patient has 11 ...
Impact of the illness on the relationship between a patient and their family 4 ...
How much difficulty a patient has with swallowing (dysphagia) 3 ...
*Each panelist chose the top 5 most important outcome domains and scored these out of 5.
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of the study, the perspectives to be assessed, and the 
resources available.34 Alternative outcome measures that 
include proxy (substitute) decision-making are, therefore, 
likely to be needed in the context of serious acute illness, 
such as severe, life-threatening stroke.14,35
The other top outcome domains included distress 
around fear of death or major disability after stroke, 
effects of stroke treatment on patients, treating patients 
as individuals, quality of care, and effective communica-
tion. The EQ-5D-5L quality of life measure can be com-
pleted by patients and families,36 as can the Integrated 
Palliative Outcomes Scale. It is a patient-reported out-
come measure designed to capture physical, psychologi-
cal, social, practical, and spiritual/existential concerns. 
Both were rated highly as outcome measures and are 
already used extensively in the United Kingdom and 
internationally. The Distress Thermometer37 comple-
ments the visual analog scale within the EQ-5D-5L. 
There is an established Stroke Specific Quality of Life 
tool designed for stroke survivors not identified by pan-
elists.38 Going forward, the complexities associated with 
shared decision-making in serious acute illness, and the 
specific challenges associated with delivering person-
centered treatment and care after stroke need to be 
considered fully in designing palliative care intervention 
studies. It is likely that a group of measures including 
those for proxy (substitute) decision-makers is required.
CONCLUSIONS
Shared decision-making and quality of life are the most 
important outcomes to measure in future trials of pallia-
tive care interventions after severe stroke. Interventions 
to improve shared decision-making and address the key 
outcome domains we have identified now need to be 
developed and tested in randomized controlled trials.
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